==================================================================================

53. Quartile Q2. Impact factor = 2.5

Davidovich P, Nikolaev D, Khadiullina R, Gurzhiy V, Bulatov E. Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis. // Bioorganic & Medicinal Chemistry Letters. 2025 Mar 1;117:130058.
DOI: 10.1016/j.bmcl.2024.130058

==================================================================================
52. Quartile Q1. Impact factor = 15.8

Ding M, Zong Q, Zhang D, Ullah I, Zhang X, Liang W, Li X, Bulatov E, Yuan Y. Self-Adaptive Nanocarriers Overcome Multiple Physiological Barriers to Boosting Chemotherapy of Orthotopic Pancreatic Cancer. // ACS Nano. 2024 Dec 28.
DOI: 10.1021/acsnano.4c11514

==================================================================================
51. Quartile Q1. Impact factor = 5.4

Chasov V, Gilyazova E, Ganeeva I, Zmievskaya E, Davletshin D, Valiullina A, Bulatov E. Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy. // Biomolecules. 2024 Dec 23;14(12):1653.
DOI: 10.3390/biom14121653

==================================================================================
50. Quartile Q3.

Mirgayazova R, Khadiullina R, Filimonova M, Chasov V, Bulatov E. Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer. // Exploration of Immunology. 2024 Dec 15;4(6):837-52.
DOI: 10.37349/ei.2024.00176

==================================================================================
49. Ядро РИНЦ (Российский журнал).

Филимонова М.Н., Хадиуллина Р.Р., Булатов Э.Р. Возможности и перспективы применения экзогенных нуклеаз в терапии онкологических заболеваний // Российский онкологический журнал. - 2024. - Т. 29. - №2. - C. 116-129.
DOI: 10.17816/onco634753

==================================================================================
48. Quartile Q1. Impact factor = 6.0

Rakhmatullina AR, Zolotykh MA, Filina YV, Valiullina AK, Zmievskaya EA, Gafurbaeva DU, Sagdeeva AR, Bulatov ER, Rizvanov AA, Miftakhova RR. Multicellular Cancer-Stroma Spheres (CSS) for In Vitro Assessment of CAR-T Cell-Associated Toxicity. // Cells. 2024 Nov 16;13(22):1892.
DOI: 10.3390/cells13221892

==================================================================================
47. Quartile Q1. Impact factor = 5.4

Khaliulin M, Valiullina A, Petukhov A, Yuan Y, Spada S, Bulatov E. Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells. // Cancer Immunology, Immunotherapy. 2024 Nov 2;74(1):3.
DOI: 10.1007/s00262-024-03817-z

==================================================================================
46. Quartile Q1. Impact factor = 6.0

Chasov V, Ganeeva I, Zmievskaya E, Davletshin D, Gilyazova E, Valiullina A, Bulatov E. Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis. // Cells. 2024 Jul 30;13(15):1282.
DOI: 10.3390/cells13151282

==================================================================================
45. Quartile Q1. Impact factor = 9.627

Liu Y, Wang H, Ding M, Yao W, Wang K, Ullah I, Bulatov E, Yuan Y. Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models. // Nano Letters. 2024 Jul 2;24(28):8741-51.
DOI: 10.1021/acs.nanolett.4c02287

==================================================================================
44. Quartile Q1. Impact factor = 4.5

Rakhmatullina AR, Zolotykh MA, Filina YV, Mingaleeva RN, Sagdeeva AR, Boulygina EA, Gafurbaeva DU, Bulatov ER, Rizvanov AA, Miftakhova RR. Development of a novel prostate Cancer-Stroma Sphere (CSS) model for In Vitro tumor microenvironment studies. // Translational Oncology. 2024 Jun 1;44:101930.
DOI: 10.1016/j.tranon.2024.101930

==================================================================================
43. Quartile Q2. Impact factor = 2.2

Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Filimonova M, Valiullina A, Kudriaeva A, Bulatov E. Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation. // Journal of Biomedical Research. 2024 May 31;38(6):531.
DOI: 10.7555/JBR.38.20240009

==================================================================================

42. Quartile Q2. Impact factor = 2.2

Chasov V, Davletshin D, Gilyazova E, Mirgayazova R, Kudriaeva A, Khadiullina R, Yuan Y, Bulatov E. Anticancer therapeutic strategies for targeting mutant p53-Y220C. // Journal of Biomedical Research. 2024 May;38(3):222.
DOI: 10.7555/JBR.37.20230093

==================================================================================

41. Quartile Q1. Impact factor = 4.1

Zmievskaya EA, Mukhametshin SA, Ganeeva IA, Gilyazova EM, Siraeva ET, Kutyreva MP, Khannanov AA, Yuan Y, Bulatov ER. Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques. // Biomedicines. 2024 Apr 20;12(4):919.
DOI: 10.3390/biomedicines12040919

==================================================================================
40. Quartile Q1. Impact factor = 5.7

Kaminskiy Y, Ganeeva I, Chasov V, Kudriaeva A, Bulatov E. Asymmetric T-cell division: Insights from cutting-edge experimental techniques and implications for immunotherapy. // Frontiers in Immunology. 2024 Mar 1;15:1301378.
DOI: 10.3389/fimmu.2024.1301378

==================================================================================
39. Quartile Q1. Impact factor = 4.7

Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Khaliulin M, Kabwe E, Davidyuk YN, Valiullina A, Rizvanov A, Bulatov E. Immunotherapy strategy for systemic autoimmune diseases: betting on CAR-T cells and antibodies.  // Antibodies. 2024 Feb 1;13(1):10.
DOI: 10.3390/antib13010010

==================================================================================
38. Quartile Q1. Impact factor = 6.1

Sultanaev V, Yakimova L, Nazarova A, Sedov I, Mostovaya O, Mukhametzyanov T, Davletshin D, Takuntseva D, Gilyazova E, Bulatov E, Stoikov I. Pillar [5] arene/albumin biosupramolecular systems for simultaneous native protein preservation and encapsulation of a water-soluble substrate. // Journal of Materials Chemistry B. 2024;12(12):3103-14.
DOI: 10.1039/D3TB02961A

==================================================================================